Table 6.
Molecular Mechanism of hucMSCs-EVs in Treating Different Diseases in the Circulatory System
| HucMSCs-EVs Cargo | Target/Signaling | Conditions/ Diseases |
Actiona | Reference |
|---|---|---|---|---|
| let-7a-5p | SMAD2 | Viral myocarditis | Ferroptosis↓ | [49] |
| None reported | AMPK/mTOR | Viral myocarditis | Apoptosis↓, cardiac function↑ | [252] |
| miR-423-5p | EFNA3 | MI | Angiogenesis↑ | [253] |
| miR-23a-3p | DMT1 | MI | Ferroptosis↓ | [254] |
| MIF | miR-133a-3p/AKT | MI | Angiogenesis↑, apoptosis↓ | [255] |
| miR-100-5p | NOX4 | Heart failure | Oxidative stress↓, apoptosis↓ | [256] |
| None reported | PI3K/Akt | Hypoxia/reoxygenation injury | Apoptosis↓ | [257] |
| PINK1 | PKA/NCLX | Myocardial injury | Protect mitochondria | [258] |
| miR-29b | None reported | MI | Fibrosis↓ | [259] |
| miR-125b-5p | Smad7 | MI | Fibrosis↓ | [260] |
| lncRNA MALAT1 | NF-κB/TNF-α | Aging-induced cardiac dysfunction | Inflammation↓ | [261] |
| None reported | p38/JNK MAPK | Atherosclerosis | Inflammation↓ | [262] |
| None reported | None reported | MI | Inflammation↓, apoptosis↓ | [263] |
| miR-136 | Apaf1 | MI | The vitality of aged stem cells↑ | [265] |
| None reported | PI3K/Akt | Heart transplantation | Myocardial ischemia-reperfusion injury↓ | [266] |
| None reported | Wnt5a | PH | Right ventricular hypertrophy↓, pulmonary vascular remodeling↓, apoptosis↓, vascular stiffening↓ | [268,269] |
| miR-147 | None reported | AAA | Inflammation↓, vascular integrity↑, aneurysm progression↓ | [270] |
| miR-126-3p | SPRED-1, PIK3R2, AKT/ERK1/2 | Vein graft | Reendothelialization↑, neointimal hyperplasia↓ | [271,272] |
| miR-148a-3p | Serpine1 | Carotid artery ligation | Neointimal hyperplasia↓ | [273] |
| miR-146a-5p | USP6 | CML | Apoptosis↑ | [274] |
| None reported | caspase-3, caspase-9 | Leukemia | Sensitivity to chemotherapy drugs↑ | [275] |
Notes: a ↑ indicates promotion or upregulation; ↓ indicates inhibition or downregulation.